A patient with a known heart condition is prescribed an antibiotic before a dental procedure. What type of antibiotic therapy is this considered?

Choice A reason: Definitive therapy targets a confirmed infection with antibiotics chosen based on culture results. Prescribing antibiotics before a dental procedure for a heart condition aims to prevent infection, not treat an existing one, making this incorrect for endocarditis prophylaxis.

Choice B reason: Empiric therapy involves antibiotics for suspected infections without confirmed pathogens. Antibiotics before dental procedures in heart patients prevent endocarditis, not treat suspected infections. This is a preventive measure based on risk, not empiric treatment, making this incorrect.

Choice C reason: Supportive therapy addresses symptoms or supports other treatments, not infection prevention. Antibiotics before dental procedures in patients with heart conditions (e.g., valvular disease) prevent bacterial endocarditis, a specific prophylactic measure, not supportive care, making this an incorrect classification.

Choice D reason: Prophylactic antibiotic therapy prevents infections in high-risk patients, such as those with heart conditions (e.g., mitral valve prolapse) before dental procedures. It reduces the risk of bacterial endocarditis from transient bacteremia, aligning with guidelines for prophylaxis in susceptible individuals, making this correct.

Choice A reason: Dehydration is not a primary concern with intravenous dexamethasone, a corticosteroid. While corticosteroids can cause fluid retention due to mineralocorticoid effects, leading to edema, they do not typically cause dehydration. Monitoring fluid status is important, but hypokalemia is a more direct electrolyte imbalance associated with corticosteroid use.

Choice B reason: Hypoglycemia is not a common side effect of dexamethasone. This corticosteroid increases blood glucose levels by promoting gluconeogenesis and insulin resistance, potentially causing hyperglycemia, especially in diabetic patients. Monitoring for elevated glucose is more relevant than hypoglycemia, which is not typically induced by corticosteroids.

Choice C reason: Hyponatremia is less likely with dexamethasone, which has minimal mineralocorticoid activity compared to drugs like hydrocortisone. It may cause fluid retention, but significant sodium depletion is rare. Hypokalemia is a more prominent electrolyte disturbance due to potassium excretion induced by corticosteroid effects on renal tubules.

Choice D reason: Hypokalemia is a known side effect of dexamethasone, as corticosteroids enhance renal potassium excretion by stimulating mineralocorticoid receptors. This disrupts electrolyte balance, potentially causing muscle weakness, arrhythmias, or fatigue. Monitoring serum potassium levels is critical during intravenous administration to prevent complications from hypokalemia in patients receiving dexamethasone.